These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 38896142)
21. Constructing immune and prognostic features associated with ADCP in hepatocellular carcinoma and pan-cancer based on scRNA-seq and bulk RNA-seq. Zhang Z; Li Y; Quan Z; Li Y; Zhu L; Sun S; Chen X Front Immunol; 2024; 15():1397541. PubMed ID: 38774870 [TBL] [Abstract][Full Text] [Related]
22. A m Xu S; Zhang Y; Yang Y; Dong K; Zhang H; Luo C; Liu SM Front Immunol; 2024; 15():1374465. PubMed ID: 39119345 [TBL] [Abstract][Full Text] [Related]
23. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma. Mo Z; Liu D; Rong D; Zhang S Front Immunol; 2021; 12():611058. PubMed ID: 33679749 [No Abstract] [Full Text] [Related]
24. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma. Gao S; Zhang L; Wang H Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264 [TBL] [Abstract][Full Text] [Related]
25. A Novel Amino Acid-Related Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma. Wang S; Huang H; Hu X; Xiao M; Yang K; Bu H; Jiang Y; Huang Z Cancer Rep (Hoboken); 2024 Jul; 7(7):e2131. PubMed ID: 39041652 [TBL] [Abstract][Full Text] [Related]
26. Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma. Qian H; Song S; Tian Y; Qi L; Gao H; Yuan L Medicine (Baltimore); 2021 Apr; 100(15):e25374. PubMed ID: 33847635 [TBL] [Abstract][Full Text] [Related]
27. Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma. Huo J; Wu L; Zang Y BMC Med Genomics; 2021 Sep; 14(1):232. PubMed ID: 34544391 [TBL] [Abstract][Full Text] [Related]
28. A prognostic signature established based on genes related to tumor microenvironment for patients with hepatocellular carcinoma. Cui Z; Li G; Shi Y; Zhao X; Wang J; Hu S; Chen C; Li G Aging (Albany NY); 2024 Apr; 16(7):6537-6549. PubMed ID: 38579170 [TBL] [Abstract][Full Text] [Related]
29. Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes. Gu X; Guan J; Xu J; Zheng Q; Chen C; Yang Q; Huang C; Wang G; Zhou H; Chen Z; Zhu H J Transl Med; 2021 Jan; 19(1):26. PubMed ID: 33407546 [TBL] [Abstract][Full Text] [Related]
30. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Tang B; Zhu J; Li J; Fan K; Gao Y; Cheng S; Kong C; Zheng L; Wu F; Weng Q; Lu C; Ji J Cell Commun Signal; 2020 Oct; 18(1):174. PubMed ID: 33115468 [TBL] [Abstract][Full Text] [Related]
31. Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma. Zhou Y; Li X; Long G; Tao Y; Zhou L; Tang J Front Immunol; 2022; 13():994259. PubMed ID: 36341373 [TBL] [Abstract][Full Text] [Related]
32. Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma. Zhou X; Liu C; Zeng H; Wu D; Liu L Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33835133 [TBL] [Abstract][Full Text] [Related]
33. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma. Huo J; Wu L; Zang Y; Dong H; Liu X; He F; Zhang X BMC Cancer; 2021 Jan; 21(1):31. PubMed ID: 33413205 [TBL] [Abstract][Full Text] [Related]
34. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma. Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373 [TBL] [Abstract][Full Text] [Related]
35. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma. Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654 [TBL] [Abstract][Full Text] [Related]
36. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177 [TBL] [Abstract][Full Text] [Related]
37. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma. Li X; Lin J; Pan Y; Cui P; Xia J Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477 [No Abstract] [Full Text] [Related]
38. Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma. Li Y; He X; Zhang X; Xu Y; Wu Y; Xu X Life Sci; 2021 Jan; 265():118799. PubMed ID: 33220285 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of the amino acid metabolism-related gene signature for prognosis, tumor immune microenvironment, and candidate drugs in hepatocellular carcinoma. Li Y; Mo H; Jia S; Wang J; Ma Y; Liu X; Tu K Front Immunol; 2022; 13():1066773. PubMed ID: 36582227 [TBL] [Abstract][Full Text] [Related]
40. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma. Chen H; Li Y; Xiao SY; Guo J BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]